Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$6.34 - $9.28 $33,697 - $49,323
5,315 New
5,315 $37,000
Q2 2023

Aug 11, 2023

BUY
$12.96 - $20.93 $89,825 - $145,065
6,931 Added 447.45%
8,480 $118,000
Q1 2023

May 15, 2023

BUY
$13.48 - $18.79 $20,880 - $29,105
1,549 New
1,549 $29,000
Q3 2022

Nov 14, 2022

SELL
$15.33 - $20.36 $48,780 - $64,785
-3,182 Reduced 76.25%
991 $19,000
Q2 2022

Aug 08, 2022

BUY
$11.63 - $21.55 $48,531 - $89,928
4,173 New
4,173 $64,000
Q4 2021

Feb 11, 2022

SELL
$20.7 - $34.18 $59,409 - $98,096
-2,870 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$19.05 - $28.32 $800 - $1,189
42 Added 1.49%
2,870 $62,000
Q2 2021

Aug 09, 2021

BUY
$18.93 - $25.65 $53,515 - $72,512
2,827 Added 282700.0%
2,828 $73,000
Q1 2021

Apr 28, 2021

BUY
$11.86 - $21.77 $11 - $21
1 New
1 $0
Q3 2020

Nov 02, 2020

SELL
$6.53 - $8.6 $1,325 - $1,745
-203 Closed
0 $0
Q2 2020

Aug 11, 2020

SELL
$4.11 - $6.78 $526 - $867
-128 Reduced 38.67%
203 $2,000
Q1 2020

May 15, 2020

SELL
$3.15 - $7.39 $28,923 - $67,854
-9,182 Reduced 96.52%
331 $1,000
Q4 2019

Feb 13, 2020

BUY
$5.01 - $8.16 $5,110 - $8,323
1,020 Added 12.01%
9,513 $74,000
Q3 2019

Oct 17, 2019

SELL
$5.07 - $7.08 $44,362 - $61,950
-8,750 Reduced 50.75%
8,493 $44,000
Q1 2019

Apr 16, 2019

BUY
$3.56 - $4.82 $18,341 - $24,832
5,152 Added 42.61%
17,243 $73,000
Q4 2018

Jan 17, 2019

BUY
$4.04 - $6.75 $25,641 - $42,842
6,347 Added 110.5%
12,091 $49,000
Q3 2018

Nov 02, 2018

BUY
$4.28 - $7.32 $18,832 - $32,208
4,400 Added 327.38%
5,744 $0
Q2 2018

Jul 24, 2018

BUY
$3.1 - $3.93 $4,166 - $5,281
1,344 New
1,344 $0

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $770M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.